Oculopharyngeal muscular dystrophy
Template:Infobox medical condition (new)
Oculopharyngeal muscular dystrophy (OPMD) is a rare form of muscular dystrophy with symptoms generally starting when an individual is 40 to 50 years old. It can be autosomal dominant neuromuscular disease or autosomal recessive. The most common inheritance of OPMD is autosomal dominant, which means only one copy of the mutated gene needs to be present in each cell. Children of an affected parent have a 50% chance of inheriting the mutant gene.[1]
Autosomal dominant inheritance is the most common form of inheritance. Less commonly, OPMD can be inherited in an autosomal recessive pattern, which means that two copies of the mutated gene need to be present in each cell, both parents need to be carriers of the mutated gene and usually show no signs or symptoms. The PABPN1 mutation contains a GCG trinucleotide repeat [2] at the 5' end of the coding region, and expansion of this repeat which then leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease.[3][4]
Signs and symptoms
Error: Image is invalid or non-existent.
In terms of the signs (and symptoms) of oculopharyngeal muscular dystrophy would be consistent with the following:[1][5]
- Ptosis
- Weakness of the extraocular muscles
- Dysphagia
- Aspiration pneumonia (complication)
- Proximal limb weakness
Though the aforementioned signs/symptoms are the most common, there have been cases though rare, where the peripheral nervous system has had involvement with significant reduction of myelinated fibers [1]
In homozygous cases, this muscular dystrophy is severe and starts earlier in the affected individual's life.[5]
Genetics
The genetics of this type of muscular dystrophy revolve around the PABPN1 gene. This gene suffers mutations that cause the PABPN1 protein to have extra alanine (amino acids), and this manifests itself physically in the symptoms of this MD.[4]
The expansion caused by the mutations on the PABPN1 gene ultimately interrupts the cellular mechanics of poly(A) RNA. In most cases oculopharyngeal muscular dystrophy is inherited via autosomal dominance.[6]
The alleles, which are a variant form of a gene[7] involved in this form of MD are: PABPN1, (GCG)n EXPANSION, (GCG)8-13, PABPN1, (GCG)n EXPANSION, (GCG)7 and PABPN1, GLY12ALA.[2]
Diagnosis
The diagnosis of oculopharyngeal muscular dystrophy can be done via two methods, a muscle biopsy or a blood draw with genetic testing for GCG trinucleotide expansions in the PABPN1 gene. Genetic blood testing is more common. Additionally, a distinction between OPMD and myasthenia gravis or mitochondrial myopathy must be made, in regards to the differential diagnosis of this condition.[1]
Treatment
Currently, no cure or specific treatment exists to eliminate the symptoms or stop the disease progression. A consistent diet planned with the help of a dietitian along with exercises taught by a speech therapist can assist with mild symptoms of dysphagia. Surgical intervention can also help temporarily manage symptoms related to ptosis and dysphagia. Cutting one of the throat muscles internally, an operation called cricopharyngeal myotomy, can be one way to ease symptoms in more severe cases. However, for most people, the benefits from such treatments are only temporary. There is currently no treatment available to address the proximal limb weakness. Many of those affected with proximal limb weakness will eventually require assistive devices such as canes, braces, or a wheelchair. As with all surgical procedures, they come with many risk factors.[8][9] As the dysphagia becomes more severe, patients become malnourished, lose significant weight, become dehydrated and suffer from repeated incidents of aspiration pneumonia. These last two are often the cause of death.[10]
Epidemiology
The disease is found across 5 continents (30 countries) and is frequently seen in French Canadians, with a prevalence 1:1000. OPMD affects males and females equally, and affected individuals have been found in Europe (France), Jewish Bukharan, and Spanish Americans.[11]
See also
References
Further reading
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Script error: No such module "Citation/CS1".
- Template:RareDiseases
External links
Template:Medical resources Template:Scholia Template:Sister project
Template:Muscular Dystrophy Template:Diseases of myoneural junction and muscle Template:Disorders of transcription and post transcriptional modification
- ↑ a b c d Script error: No such module "citation/CS1".update 2014
- ↑ a b Script error: No such module "citation/CS1".
- ↑ https://www.ncbi.nlm.nih.gov/gene/8106 Template:Webarchive "PABPN1 poly(A) binding protein, nuclear 1 [ Homo sapiens (human) ]"]11 OCT 2014.
- ↑ a b Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".